Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
After finishing at $47.07 in the prior trading day, Novo Nordisk ADR (NYSE: NVO) closed at $48.19, up 2.38%. In other words, the price has increased by $2.38 from its previous closing price. On the day, 34.69 million shares were traded. NVO stock price reached its highest trading level at $49.03 during the session, while it also had its lowest trading level at $47.56.
Ratios:
Our goal is to gain a better understanding of NVO by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 26.96 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 11.36. For the most recent quarter (mrq), Quick Ratio is recorded 0.56 and its Current Ratio is at 0.74. In the meantime, Its Debt-to-Equity ratio is 0.86 whereas as Long-Term Debt/Eq ratio is at 0.70.
BMO Capital Markets Downgraded its Outperform to Market Perform on April 17, 2025, while the target price for the stock was maintained at $64.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on May 30 ’25 when Novo Nordisk A/S bought 921,897 shares for $2.14 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NVO now has a Market Capitalization of 209972019200 and an Enterprise Value of 291112517632. As of this moment, Novo’s Price-to-Earnings (P/E) ratio for their current fiscal year is 14.29, and their Forward P/E ratio for the next fiscal year is 11.01. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.94. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.72 while its Price-to-Book (P/B) ratio in mrq is 10.67. Its current Enterprise Value per Revenue stands at 0.96 whereas that against EBITDA is 1.875.
Stock Price History:
The Beta on a monthly basis for NVO is 0.63, which has changed by -0.61753964 over the last 52 weeks, in comparison to a change of 0.20277917 over the same period for the S&P500. Over the past 52 weeks, NVO has reached a high of $139.74, while it has fallen to a 52-week low of $46.90. The 50-Day Moving Average of the stock is -30.28%, while the 200-Day Moving Average is calculated to be -41.74%.
Shares Statistics:
The stock has traded on average 12.64M shares per day over the past 3-months and 31559130 shares per day over the last 10 days, according to various share statistics. A total of 3.37B shares are outstanding, with a floating share count of 3.37B. Insiders hold about 0.00% of the company’s shares, while institutions hold 9.66% stake in the company. Shares short for NVO as of 1752537600 were 23584063 with a Short Ratio of 1.87, compared to 1749772800 on 26611463. Therefore, it implies a Short% of Shares Outstanding of 23584063 and a Short% of Float of 0.69999998.
Dividends & Splits
In the trailing 12 months, NVO’s forward annual dividend rate was 11.4, compared to 1.66 this year. Against a Trailing Annual Dividend Yield of 0.24219248The stock’s 5-year Average Dividend Yield is 1.49. The current Payout Ratio is 35.93% for NVO, which recently paid a dividend on 2025-03-31 with an ex-dividend date of 2025-03-31. Stock splits for the company last occurred on 2023-09-20 when the company split stock in a 2:1 ratio.
